跳至主要内容
临床试验/ACTRN12624000491561
ACTRN12624000491561尚未招募Unknown

Impact of the New Zealand pine bark extract (Enzogenol®) on sucrose metabolism and glycaemic responses in healthy adults – a single-blind, randomised, placebo-controlled, crossover trial

Riddet Institute, Massey University0 个研究点目标入组 40 人开始时间: 2024年4月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • The inclusion criteria will be:
  • Healthy participants (males and females)
  • Aged between 18-60 years old
  • Body Mass Index (BMI) of 18.5-29.9kg/m2 (Healthy and overweight)
  • Glycated haemoglobin A1c (HbA1c) <39 mmol/mol (ADA guidelines)
  • Fasting blood glucose (FBG) <5.6 mmol/L (ADA guidelines)
  • Able to communicate well in English

排除标准

  • The exclusion criteria will be:
  • Body Mass Index (BMI) >29.9kg/m2 (obese)
  • Glycated haemoglobin A1c (HbA1c) >39 mmol/mol (ADA guidelines)
  • Fasting blood glucose (FBG) >5.6 mmol/L (ADA guidelines)
  • Known food allergies or intolerance to pine bark extract or mulberry leaf extract
  • Having dietary restrictions or dietary disorders
  • Pre-existing medical conditions (cardiovascular disease, hypertension, diabetes etc.) or taking medications including anti-hyperglycaemic drugs and insulin known to affect glucose metabolism or regulation
  • Use of steroids, protease inhibitors or antipsychotics medicines known to influence glucose metabolism and body fat distribution
  • Pregnant or breastfeeding

研究者

发起方
Riddet Institute, Massey University

相似试验